Skip to main content

HPV vaccines: Gardasil becomes a market dud in wake of informed backlash

Submitted by Marc Angles on

(NaturalNews) On the heels of the Vioxx scandal Merck & Co. has apparently manufactured another marketplace dud with Gardasil. After receiving fast-track approval from the FDA in 2006, Merck's aggressive 'One More Girl' marketing campaign catapulted HPV into the collective consciousness as a serious health issue. Almost overnight, medical consumers went from not knowing HPV existed to fear of infection with the dreaded virus. Presto! HPV pandemonium was born.

• Over 70% of the participants in Gardasil clinical trials developed new medical conditions

• The vaccine may increase chances of pre-cancerous lesions in individuals who have already been exposed to vaccine relevant HPV by 44.6%

• Clinical trials conducted by Merck in India were shut down after the deaths of 6 young women and ethics violations...